Newly diagnosed Multiple Myeloma patients with high levels of circulating tumor cells are distinguished by increased bone marrow plasma cell proliferation

被引：0
|
作者：
Fokkema, A. Cathelijne [1 ]
De Jong, Madelon [1 ]
Tahri, Sabrin [1 ]
Kellermayer, Zoltan [1 ]
Den Hollander, Chelsea [1 ]
Vermeulen, Michael [1 ]
Papazian, Natalie [1 ]
Van Duin, Mark [1 ]
Broijl, Annemiek [1 ]
Sonneveld, Pieter [1 ]
Cupedo, Tom [1 ]
机构：
[1] Erasmus MC Canc Inst, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-014
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [31] Flow Cytometric Determination of Circulating Plasma Cells in Newly Diagnosed Myeloma
    Mohapatra, P. N.
    Iqbal, S.
    Kumar, R.
    Sharma, A.
    Raina, V.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S88 - S88
  • [32] Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
    Mellors, Patrick W.
    Binder, Moritz
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Baughn, Linda B.
    Peterson, Jess F.
    Jevremovic, Dragan
    Pearce, Kathryn E.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kapoor, Prashant
    Gonsalves, Wilson, I
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam
    Kourelis, Taxiarchis
    Warsame, Rahma
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD ADVANCES, 2020, 4 (10) : 2236 - 2244
  • [33] Prognostic Relevance of the Proportion of Residual Polyclonal Plasma Cells in the Diagnostic Bone Marrow of Newly Diagnosed Multiple Myeloma Patients Managed Without Autologous Stem Cell Transplantation
    Tembhare, Prashant
    Gudapati, Prathyusha
    Ghogale, Sitaram
    Inamdar, Nitin
    Khanka, Twinkle
    Deshpande, Nilesh
    Yajamanam, Badrinath
    Chatterjee, Gaurav
    Gawai, Sangamitra
    Amare, Prathibha
    Bagal, Bhausaheb
    Jain, Hasmukh
    Patkar, Nikhil
    Sengar, Manju
    Khattry, Navin
    Subramanian, P. G.
    Gujral, Sumeet
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E238 - E239
  • [34] Circulating Plasma Cells in Newly Diagnosed Symptomatic Multiple Myeloma As a Prognostic Marker for Patients with Standard-Risk Cytogenetics
    Vagnoni, Davide
    Travaglini, Fosco
    Angelini, Stefano
    Dalsass, Alessia
    Mestichelli, Francesca
    Angelini, Mario
    Pezzoni, Valerio
    Natale, Annalisa
    Ruggieri, Miriana
    Bigazzi, Catia
    Troiani, Emanuela
    Falcioni, Sadia
    Mazzotta, Serena
    Galieni, Piero
    BLOOD, 2014, 124 (21)
  • [35] Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma
    Sathya, Pandurangan
    Kayal, Smita
    Srinivas, B. H.
    Hamide, Abdoul
    Kar, Rakhee
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (06) : 917 - 926
  • [36] Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.
    Siragusa, Sergio
    Morice, William
    Gertz, Morie A.
    Kyle, Robert
    Greipp, Philip R.
    Lust, John A.
    Witzig, Thomas E.
    Lacy, Martha Q.
    Zeldenrust, Steven R.
    Rajkumar, S. Vincent
    Hayman, Suzanne R.
    Buadi, Francis
    Russell, Stephen J.
    Kumar, Shaji
    Dingli, David
    Dispenzieri, Angela
    BLOOD, 2009, 114 (22) : 1096 - 1096
  • [37] Prognostic Impact of Bone Marrow Erythropoiesis on Newly Diagnosed Plasma Cell Myeloma: A Single Institutional Analyses
    Ezekwudo, Daniel E.
    Singh, Rohit
    Gbadamosi, Bolanle
    Micale, Mark
    Jaiyesimi, Ishmael
    Smith, Marc
    BLOOD, 2018, 132
  • [38] Relationship Between Serum Periostin Level and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma Patients
    Tuna, Ali Kursat
    Tekinalp, Atakan
    Kilinc, Ibrahim
    Demircioglu, Sinan
    Kaya, Bahattin Engin
    Ceneli, Ozcan
    Kilinc, Fahriye
    NAMIK KEMAL MEDICAL JOURNAL, 2023, 11 (02): : 158 - 162
  • [39] More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
    Mengru Tian
    Xinyue Liang
    Weiling Xu
    Xingcheng Yi
    Tingting Yue
    Yingjie Zhang
    Shanshan Yu
    Yurong Yan
    Zhongli Hu
    Nan Zhang
    Jingxuan Wang
    Rui Hu
    Xiaoxiao Sun
    Yuanyuan Nie
    Yun Dai
    Fengyan Jin
    Annals of Hematology, 2023, 102 : 2943 - 2945
  • [40] Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates
    Liu, Yang
    Guo, Jiapei
    Yi, Yuting
    Gao, Xuan
    Wen, Lei
    Duan, Wenbing
    Wen, Zhaohong
    Liu, Yaoyao
    Guan, Yanfang
    Xia, Xuefeng
    Ma, Ling
    Fu, Rong
    Liu, Lihong
    Huang, Xiaojun
    Ge, Qing
    Lu, Jin
    CANCERS, 2022, 14 (19)
12345